
============================================================
                   AKTIENANALYSE: NOV.DE                    
============================================================
Firmendaten werden abgerufen...
+-------------+------------------------------+------------------------------+
| Kategorie   | Details                      | ErlÃ¤uterung                  |
+=============+==============================+==============================+
| Unternehmen | Novo Nordisk A/S             | Name des Unternehmens        |
+-------------+------------------------------+------------------------------+
| Sektor      | Healthcare                   | Wirtschaftssektor            |
+-------------+------------------------------+------------------------------+
| Branche     | Drug Manufacturers - General | Industrie oder GeschÃ¤ftsfeld |
+-------------+------------------------------+------------------------------+
| Land        | Denmark                      | Herkunftsland                |
+-------------+------------------------------+------------------------------+

Kurzbeschreibung: Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, ...

Historische Daten werden abgerufen...
Historische Daten erfolgreich abgerufen.

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
            KURSVERLAUF VISUALISIERUNG            
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
ASCII-ART KURSVERLAUF (Letzte 90 Tage)
Hoch: 76.46 | Tief: 51.88
--------------------------------------------------
         *                                                                                
       ** **** *                                                                          
              * *                                                                         
*   ***          *                                                               ****     
 ***                                                                           **    *    
                  *    ****     ***                                        * **       ****
                   ****    ***     **                 **          **  ***** *             
                              *      ***   **        *  ******** *  **                    
                               *          *  *   * **           *                         
                                        **    *** *                                       
--------------------------------------------------
Datenpunkte: Jeder * reprÃ¤sentiert einen Tag
Nicht genÃ¼gend gemeinsame Datenpunkte fÃ¼r Performance-Vergleich im angegebenen Zeitraum (letzte 252 Handelstage).

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                TECHNISCHE ANALYSE                
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+----------------+---------+---------------------------------+
| Kategorie      | Wert    | ErlÃ¤uterung                     |
+================+=========+=================================+
| Aktueller Kurs | $63.62  | Letzter Schlusskurs             |
+----------------+---------+---------------------------------+
| TagesÃ¤nderung  | -2.8%   | Prozentuale Ã„nderung zum Vortag |
+----------------+---------+---------------------------------+
| Volumen        | N/A     | Gehandeltes Volumen             |
+----------------+---------+---------------------------------+
| MA(20)         | $64.78  | 20-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(50)         | $60.43  | 50-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(200)        | $76.35  | 200-Tage-Durchschnitt           |
+----------------+---------+---------------------------------+
| RSI(14)        | 50.7    | Relative Strength Index         |
+----------------+---------+---------------------------------+
| 52W Hoch       | $118.20 | 52-Wochen-HÃ¶chstkurs            |
+----------------+---------+---------------------------------+
| 52W Tief       | $50.47  | 52-Wochen-Tiefstkurs            |
+----------------+---------+---------------------------------+
| VolatilitÃ¤t    | 39.8%   | JÃ¤hrliche VolatilitÃ¤t           |
+----------------+---------+---------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
             FUNDAMENTALE KENNZAHLEN              
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+----------------------+---------------------+-----------------------------------------+
| Kategorie            | Wert                | ErlÃ¤uterung                             |
+======================+=====================+=========================================+
| Marktkapitalisierung | $283,416,297,472.00 | Gesamtwert der Aktien                   |
+----------------------+---------------------+-----------------------------------------+
| KGV (P/E)            | 20.20               | Kurs-Gewinn-VerhÃ¤ltnis                  |
+----------------------+---------------------+-----------------------------------------+
| Forward P/E          | N/A                 | Erwartetes KGV                          |
+----------------------+---------------------+-----------------------------------------+
| Dividendenrendite    | 3.33%               | Dividende im VerhÃ¤ltnis zum Kurs        |
+----------------------+---------------------+-----------------------------------------+
| Verschuldungsgrad    | 85.70               | VerhÃ¤ltnis von Schulden zu Eigenkapital |
+----------------------+---------------------+-----------------------------------------+

Bewertung der fundamentalen Kennzahlen:
- pe_ratio: Durchschnittlich
- dividend_yield: Gut (hohe Rendite)
- debt_to_equity: Schlecht (hohe Verschuldung)

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
            DCF SCHÃ„TZUNG & SZENARIEN             
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+--------------------------+------------+----------+---------------------------------------------+
| Szenario                 | DCF Wert   | Upside   | Annahmen                                    |
+==========================+============+==========+=============================================+
| Basis-Szenario           | $369.65    | 481.0%   | Annahmen: Wachstum 0.1%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+
| Optimistisches Szenario  | $470.29    | 639.2%   | Annahmen: Wachstum 0.1%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+
| Pessimistisches Szenario | $264.09    | 315.1%   | Annahmen: Wachstum 0.0%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
               SENSITIVITÃ„TSANALYSE               
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-----------------+----------------------+------------+
| Wachstumsrate   | Diskontierungsrate   | DCF Wert   |
+=================+======================+============+
| Wachstum 0.0%   | Diskontierung 0.1%   | $264.09    |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | $339.55    |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | $396.14    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $286.72    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $369.65    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $431.88    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $310.99    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $401.98    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $470.29    |
+-----------------+----------------------+------------+

==============================
Gesamtbewertung abgeschlossen 
==============================

+-------------+------------------------------+------------------------------+
| Kategorie   | Details                      | ErlÃ¤uterung                  |
+=============+==============================+==============================+
| Unternehmen | Novo Nordisk A/S             | Name des Unternehmens        |
+-------------+------------------------------+------------------------------+
| Sektor      | Healthcare                   | Wirtschaftssektor            |
+-------------+------------------------------+------------------------------+
| Branche     | Drug Manufacturers - General | Industrie oder GeschÃ¤ftsfeld |
+-------------+------------------------------+------------------------------+
| Land        | Denmark                      | Herkunftsland                |
+-------------+------------------------------+------------------------------+
+----------------+---------+---------------------------------+
| Kategorie      | Wert    | ErlÃ¤uterung                     |
+================+=========+=================================+
| Aktueller Kurs | $63.62  | Letzter Schlusskurs             |
+----------------+---------+---------------------------------+
| TagesÃ¤nderung  | -2.8%   | Prozentuale Ã„nderung zum Vortag |
+----------------+---------+---------------------------------+
| Volumen        | N/A     | Gehandeltes Volumen             |
+----------------+---------+---------------------------------+
| MA(20)         | $64.78  | 20-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(50)         | $60.43  | 50-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(200)        | $76.35  | 200-Tage-Durchschnitt           |
+----------------+---------+---------------------------------+
| RSI(14)        | 50.7    | Relative Strength Index         |
+----------------+---------+---------------------------------+
| 52W Hoch       | $118.20 | 52-Wochen-HÃ¶chstkurs            |
+----------------+---------+---------------------------------+
| 52W Tief       | $50.47  | 52-Wochen-Tiefstkurs            |
+----------------+---------+---------------------------------+
| VolatilitÃ¤t    | 39.8%   | JÃ¤hrliche VolatilitÃ¤t           |
+----------------+---------+---------------------------------+
+----------------------+---------------------+-----------------------------------------+
| Kategorie            | Wert                | ErlÃ¤uterung                             |
+======================+=====================+=========================================+
| Marktkapitalisierung | $283,416,297,472.00 | Gesamtwert der Aktien                   |
+----------------------+---------------------+-----------------------------------------+
| KGV (P/E)            | 20.20               | Kurs-Gewinn-VerhÃ¤ltnis                  |
+----------------------+---------------------+-----------------------------------------+
| Forward P/E          | N/A                 | Erwartetes KGV                          |
+----------------------+---------------------+-----------------------------------------+
| Dividendenrendite    | 3.33%               | Dividende im VerhÃ¤ltnis zum Kurs        |
+----------------------+---------------------+-----------------------------------------+
| Verschuldungsgrad    | 85.70               | VerhÃ¤ltnis von Schulden zu Eigenkapital |
+----------------------+---------------------+-----------------------------------------+
+-------------+--------+---------------+
| Kategorie   | Wert   | ErlÃ¤uterung   |
+=============+========+===============+
+-------------+--------+---------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
           AKTIENSTRATEGIE & EMPFEHLUNG           
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-------------------+---------------------------------------------------------------------+--------------------------------------------+
| Kategorie         | Wert                                                                | ErlÃ¤uterung                                |
+===================+=====================================================================+============================================+
| Kategorie         | Wert                                                                | ErlÃ¤uterung                                |
+-------------------+---------------------------------------------------------------------+--------------------------------------------+
| Gesamtempfehlung  | ðŸŸ¢ Kaufen                                                            | Zusammenfassende Bewertung der Aktie.      |
+-------------------+---------------------------------------------------------------------+--------------------------------------------+
| StÃ¤rken           | Hohe Dividendenrendite                                              | Positive Aspekte der Analyse.              |
+-------------------+---------------------------------------------------------------------+--------------------------------------------+
| SchwÃ¤chen/Risiken | Hoher Verschuldungsgrad                                             | Negative Aspekte oder potenzielle Risiken. |
+-------------------+---------------------------------------------------------------------+--------------------------------------------+
| BegrÃ¼ndung        | Forward P/E: N/A, Dividende: 333.00%, DCF: 369.64879811560746 (EUR) | GrÃ¼nde fÃ¼r die Bewertung.                  |
+-------------------+---------------------------------------------------------------------+--------------------------------------------+
| Kaufzone          | 369.64879811560746 (EUR)                                            | Preisbereich fÃ¼r den Einstieg.             |
+-------------------+---------------------------------------------------------------------+--------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                DIVIDENDENWACHSTUM                
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+---------------+-----------------+
| Kategorie     | Wert            |
+===============+=================+
| Jahr          | Dividende (EUR) |
+---------------+-----------------+
| 2016          | $4.08           |
+---------------+-----------------+
| 2017          | $3.30           |
+---------------+-----------------+
| 2018          | $3.41           |
+---------------+-----------------+
| 2019          | $3.54           |
+---------------+-----------------+
| 2020          | $3.73           |
+---------------+-----------------+
| 2021          | $4.06           |
+---------------+-----------------+
| 2022          | $4.84           |
+---------------+-----------------+
| 2023          | $6.14           |
+---------------+-----------------+
| 2024          | $8.59           |
+---------------+-----------------+
| 2025          | $6.85           |
+---------------+-----------------+
| Wachstumsrate | 5.94%           |
+---------------+-----------------+
Bewertung: Volatiles Wachstum mit durchschnittlich 5.94% pro Jahr.
